Biostem Technologies Inc
OTC:BSEM

Watchlist Manager
Biostem Technologies Inc Logo
Biostem Technologies Inc
OTC:BSEM
Watchlist
Price: 13.922 USD 3.2% Market Closed
Market Cap: 227.5m USD
Have any thoughts about
Biostem Technologies Inc?
Write Note

Relative Value

The Relative Value of one BSEM stock under the Base Case scenario is 34.936 USD. Compared to the current market price of 13.922 USD, Biostem Technologies Inc is Undervalued by 60%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BSEM Relative Value
Base Case
34.936 USD
Undervaluation 60%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
95
vs Industry
44
Median 3Y
4.3
Median 5Y
6.3
Industry
2.5
Forward
0.8
vs History
6
vs Industry
0
Median 3Y
-9.1
Median 5Y
-10.3
Industry
21.9
Forward
9.5
vs History
15
vs Industry
Median 3Y
-14.2
Median 5Y
-10.5
Industry
16.5
vs History
26
vs Industry
Median 3Y
38.3
Median 5Y
5.3
Industry
23.6
vs History
15
vs Industry
2
Median 3Y
-6.3
Median 5Y
-2.3
Industry
2.1
vs History
95
vs Industry
43
Median 3Y
4.8
Median 5Y
7.8
Industry
2.6
Forward
0.8
vs History
95
vs Industry
64
Median 3Y
6.2
Median 5Y
9.5
Industry
5.2
vs History
11
vs Industry
1
Median 3Y
-13.3
Median 5Y
-15.8
Industry
13.3
vs History
11
vs Industry
1
Median 3Y
-10.7
Median 5Y
-13.3
Industry
16.6
Forward
25.7
vs History
15
vs Industry
Median 3Y
-14.8
Median 5Y
-11.2
Industry
15.6
vs History
6
vs Industry
Median 3Y
-25.6
Median 5Y
-20.9
Industry
19.1
vs History
92
vs Industry
24
Median 3Y
10.2
Median 5Y
9.1
Industry
1.9

Multiples Across Competitors

BSEM Competitors Multiples
Biostem Technologies Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Biostem Technologies Inc
OTC:BSEM
227.5m USD 1.1 15.9 10.3 10.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
US
Biostem Technologies Inc
OTC:BSEM
Average P/E: 30.3
15.9
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top